Paul Szabolcs is an Oncology physician. OpenAlex indexes 244 publications with 7,278 citations (h-index 39); ClinicalTrials.gov lists 9 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2100 Erwin Rd
Durham, NC 277100001
Telephone
919-620-5042Registry record last updated 2 Aug 2010.
Clinical trials
- Anti-viral T-cell Therapy by Gamma Capture
Sponsor: Paul Szabolcs
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
4 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments$11,074openpaymentsdata.cms.gov ↗
- Mesoblast, Inc.Program year20251 payment
- SANOFI-AVENTIS U.S. LLCProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
1 NIH research award on record, funded 2007–2010 per NIH RePORTER. The latest:
- Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation
Duke University
FY2010$296,400R01CA132110 - Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation
Duke University
FY2009$297,920R01CA132110 - Graft Engineering and Immunotherapy After Unrelated Cord Blood Transplantation
Duke University
FY2008$300,960R01CA132110
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome
Journal of Allergy and Clinical Immunology
2022 - The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions
Journal of Allergy and Clinical Immunology
2022 - Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations
Journal of Allergy and Clinical Immunology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”